TOMAS ZABRANSKY

Tomas Zabransky graduated from Medical Faculty, Palacky University Olomouc in 1993, where he also received Ph.D. in epidemiology, hygiene and preventive medicine in 2001. Tomas Zabransky was, inter alia, a principal researcher of the multidisciplinary PAD Study, which evaluated the impacts of amendments in the Czech drug legislature (1999) as requested by the Czech Government. He was responsible for establishing the Czech National Focal Point on Monitoring the Drug Situation and Addictions in 2000-2002; recently, he serves as Reader in Addiction Science and Department of Addictology, Charles University, Prague, and at the Department of Epidemiology, Hygiene and Preventive Medicine at the Medical Faculty of the Palacky University. Since 2001, he runs a private research, education and consulting company ResAd LLC. In December 2015, he co-founded biomedical startup International Cannabinoids and Cannabinoids Institute, where he has served as Chief Scientist. Between March 2014 and October 2017, Tomas served as Advisor on Drug Policy to the Czech Prime Minister; in 2014-16 he was an advisor on Medical Cannabis and Drug Policy to the Czech Minister of Health, in 2006-9, he served as Drug Policy Advisor to the Czech Minister of Interior, responsible, inter alia, for coordinating of the drug policy issues in the time of the Czech Presidency to the EU Council. Since 2015, Tomas is a Member of the EMCDDA Management Board elected by the EU Parliament. He published over 120 peer-reviewed journal papers and chapters in monographs and authored two textbooks. Tomas is Deputy Editor of the scientific journal Harm Reduction Journal (Biomed Central), Deputy Editor of the scientific journal Medical Cannabis and Cannabinoids (Karger), and Member of the Board of the International Society for Studies of Drug Policies.